Loading chat...
NJ A6151
Bill
Status
12/4/2025
Primary Sponsor
Lisa Swain
Click for details
AI Summary
-
Over-the-counter and prescription drugs containing ingredients derived from major food allergens or gluten-containing grains must bear labels clearly identifying those ingredients and specifying the type of gluten-containing grain where applicable
-
Drugs failing to comply with labeling requirements will be deemed misbranded, and the Commissioner of Health may order label corrections within a specified timeframe
-
Penalties for misbranding violations are $500 for a first offense, $1,000 for a second offense, and $2,000 for third and subsequent offenses
-
The Department of Health is authorized to investigate labeling accuracy and will adopt rules and regulations to implement the requirements
-
The act takes effect 25 months after enactment to allow manufacturers time to comply with the new labeling standards
Legislative Description
Requires labeling of over-the-counter and prescription drugs containing major food allergen or gluten-containing grain.
Health
Last Action
Introduced, Referred to Assembly Health Committee
12/4/2025